K Vandenbroeck (UPV)
The group focuses on the identification and functional characterization of genes involved in the pathogenesis of multiple sclerosis, as well as on novel anti-inflammatory therapies.
The main contributions to REEM are:
- Identification and validation of MS risk genes in the Spanish population in collaboration with E Urcelay, F Matesanz, M Comabella.
- Pharmacogenomics of MS therapies in collaboration with M Comabella, G Izquierdo/F Matesanz, E Urcelay.
- Analysis of the role of immune response in CNS damage in collaboration with P Villoslada/Garcia-Ojalvo, O Fernandez, F de Castro and C Guaza.